The Application Notebook
The flexibility to use short sub-2 micron columns on UHPLC instruments at high flow-rates permits fast analysis with high resolution of complex samples. An Agilent ZORBAX Rapid Resolution High Definition (RRHD) Eclipse Plus C18 1.8 µm column separated seven different biocides in less than 1 minute with high resolution. A flow-rate of 1.7 mL/min was used on 2.1 × 50 mm column to achieve the rapid separation. The Agilent 1290 Infinity LC system was used as the column pressure just exceeded 1000 bar at this high flow-rate. A sample of hand sanitizer was found to contain 2-phenoxyethanol and methylparaben using the method.
The flexibility to use short sub-2 micron columns on UHPLC instruments at high flow-rates permits fast analysis with high resolution of complex samples. An Agilent ZORBAX Rapid Resolution High Definition (RRHD) Eclipse Plus C18 1.8 µm column separated seven different biocides in less than 1 minute with high resolution. A flow-rate of 1.7 mL/min was used on 2.1 × 50 mm column to achieve the rapid separation. The Agilent 1290 Infinity LC system was used as the column pressure just exceeded 1000 bar at this high flow-rate. A sample of hand sanitizer was found to contain 2-phenoxyethanol and methylparaben using the method.
Biocides are used to control harmful organisms such as bacteria, fungi and rodents and help protect health, improve product performance and prevent spoilage. They are found in many areas including medicine, agriculture, forestry and in industry and are highly regulated because of their potential health risk to humans or the environment. The demand for biocides will continue to increase as the public and consumers' awareness of the benefits of continued improvements in hygiene grows. Many biocides are synthetic and this work includes the fast separation of seven different synthetic biocides used in various applications.
Figure 1: Rapid UHPLC separation of biocides and analysis of hand sanitizer on Agilent ZORBAX RRHD columns.
Instrumentation and chromatographic parameters are found in Figure 1. A 100 ppm stock solution (50/50 ACN/H2O) of the biocide standards was diluted with 5% ACN in H2O to make a 50 ppm standard mix.
Seven different biocides were easily separated in only 0.7 minutes on an RRHD Eclipse Plus C18 1.8 μm column as shown in Figure 1. All compounds were baseline resolved with a minimum resolution factor of 1.8. A very fast linear gradient and high flow-rate of 1.7 mL/min on the 50 mm RRHD column produced pressure over 1000 bar. RRHD columns are designed for UHPLC systems such as the Agilent 1290 Infinity operating at pressures up to 1200 bar. UV detection included programmed wavelength switching to maximize detection response and improve sensitivity. Analysis of all standards showed linearity from 3 to 25 ppm.
Hand sanitizer was analysed as shown in the bottom half of Figure 1. The sanitizer was injected neat (2 μL) with no detrimental effects. Two biocides, 2-phenoxyethanol and methylparaben, which are common preservatives in personal care products, were identified without difficulty with the fast method. To assist in MS detection, 0.1% formic acid can be substituted for the trifluoroacetic acid.
The ZORBAX RRHD Eclipse Plus C18 1.8 μm column was used in conjunction with the Agilent 1290 Infinity LC for a fast, high resolution separation of biocides. The rapid analysis method was successfully applied to the separation and identification of two biocides in a hand sanitizer. Benefits include speed with high resolution for improved productivity.
Derek J. Knight and Mel Cooke, "The Biocide Business: Regulation, Safety and Applications," Wiley-VCH 2002.
Agilent Technologies Inc.
2850 Centerville Road, Wilmington, Delaware 19808, USA
tel. +1 800 227 9770 fax +1 302 633 8901
E-mail: info_agilent@agilent.com Website: www.agilent.com/chem
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.